Sucralfate Suspension
FDA Label NDC 55154-5790

19 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Sucralfate (NDC 55154-5790). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, clinical trials, indications and usage, contraindications, warnings, precautions, special populations: chronic renal failure and dialysis patients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-5790-5

SUCRALFATE ORAL SUSPENSION

1 g/10 mL

5 CUPS

1g/10ml Bag Label (2271d920 944f 42ac 9de4 2c09447a55b3 00)

1g/10ml Bag Label (2271d920 944f 42ac 9de4 2c09447a55b3 00)

* Please review the disclaimer below.